CytRx Corp (CYTR.OQ)
CYTR.OQ on NASDAQ Stock Exchange Capital Market
0.60USD
19 Feb 2019
0.60USD
19 Feb 2019
Change (% chg)
$0.00 (+0.35%)
$0.00 (+0.35%)
Prev Close
$0.60
$0.60
Open
$0.61
$0.61
Day's High
$0.61
$0.61
Day's Low
$0.59
$0.59
Volume
28,064
28,064
Avg. Vol
27,710
27,710
52-wk High
$2.18
$2.18
52-wk Low
$0.35
$0.35
About
CytRx Corporation is a biopharmaceutical research and development company specializing in oncology. The Company is focused on the clinical development of aldoxorubicin, its modified version of the chemotherapeutic agent, doxorubicin. It is engaged in Phase III trials for aldoxorubicin as a therapy for patients with soft tissue... (more)
Overall
| Beta: | 2.34 |
| Market Cap(Mil.): | $69.25 |
| Shares Outstanding(Mil.): | 165.83 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| CYTR.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 69.44 | 33.70 |
| EPS (TTM): | -0.41 | -- | -- |
| ROI: | -112.76 | 8.92 | 14.45 |
| ROE: | -214.05 | 10.08 | 15.96 |
Estimates